Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

ACUR

Acura Pharmaceuticals (CE) (ACUR)

Acura Pharmaceuticals Inc (CE)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:ACUR
일자시간출처헤드라인심볼기업
2024/05/1521:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/05/1505:40Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/02/1500:53Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/02/0300:27Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/01/1107:13Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/01/0305:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/01/0305:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/01/0305:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/01/0305:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/12/2202:01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/12/0704:35Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/11/2102:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/11/2102:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/11/2102:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/11/2102:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/11/0401:42Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/10/1301:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/09/2605:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/09/0120:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/09/0105:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/08/3105:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/08/1700:20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/08/1101:17Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/07/2905:41Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/07/2900:50Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/07/1322:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/07/0103:04Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/07/0102:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/07/0100:53Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/06/2821:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ACURAcura Pharmaceuticals Inc (CE)
 검색 관련기사 보기:USOTC:ACUR